1. A pharmaceutical composition for the treatment and \ or prevention of a condition requiring correction weight, comprising as active ingredient a compound of peptide Pro-Val-Asn-Phe-Lys-Phe-Leu-Ser-His, and a pharmaceutically acceptable carrier at the following ratio of components, wt.%: 2. A pharmaceutical composition according to claim 1, wherein the condition requiring correction weight is selected from obesity, body weight gain, change in the component composition tela.3. A pharmaceutical composition according to claim 2, wherein the change in the body composition component implies an increase in the proportion of fat in organizme.4. A pharmaceutical composition according to claim 1, made in a form suitable for sublingual vvedeniya.5. A pharmaceutical composition according to claim 1, made in a form suitable for nasal vvedeniya.6. A pharmaceutical composition according to claim 1, made in a form applicable to oral vvedeniya.7. A pharmaceutical composition according to claim 1, made in a form acceptable for inclusion in the composition of dietary supplement to pische.8. A pharmaceutical composition according to pp.4-7, wherein a single dose of active ingredient is from about 12 ug to 250 mkg9. A pharmaceutical composition according to pp.4-7, wherein the daily dose of the active component is from 48 micrograms to 500 mkg.10. An agent for treating and \ or prevention of a condition that requires weight adjustments, including the composition of the p.111. A compound according to claim 10, wherein the condition requiring correction weight is selected from obesity, body weight gain, change in the component composition tela.12. A compound according to claim 10, configured in a form suitable for nasal vvedeniya.13. A compound according to claim 10, configured in a form suitable for sublingual vvedeniya.14. A compound according to claim 12 yl1. Фармацевтическая композиция для лечения и\или предупреждения состояния, требующего корректировки веса, включающая в качестве
